Published by Josh White on 28th March 2022
(Sharecast News) - Monoclonal antibody developer and supplier Bioventix reported an 8% fall in revenue in its first half on Monday, to £4.7m.
URL: http://www.digitallook.com/dl/news/story/32562449/...